Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.

Detalhes bibliográficos
Autor(a) principal: Ponce, P
Data de Publicação: 1994
Outros Autores: Gusmão, L, Adragão, T, Bruges, M, Gomes, E M, Antunes, J
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2891
Resumo: To study the effect of the correction of post-transplantation Hypophosphatemia on mineral metabolism.15 patients with renal transplants for 3 to 12 months, Serum Creatinine "177 micmol/1, were treated with oral phosphorus (P) for persistent hypophosphatemia.3 periods of blood and urine collection at intervals of 3 weeks. T1 under basal treatment with oral P, T2 after 3 weeks off medication with P, Ca, or P binders. T3 3 weeks after going back on oral P supplements.Serum P dropped from T1 to T2 (1.03 +/- 0.03 mmol/L to 0.83 +/- 0.03 mmol/L, p "0.0001), rising again in T3 to 1.06 +/- 0.03 mmol/L. From T1 to T2, PTHi decreased from 95.4 +/- 8.7 to 66.8 8.9pg/ml), osteocalcin rose from 3.8 +/- 1.2 to 16.6 +/- 2.3ng/ml (p
id RCAP_1310468aa173c9464984cc63c72490e8
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/2891
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.Consequências no metabolismo mineral da correcção da hipofosfatemia pós-transplante.To study the effect of the correction of post-transplantation Hypophosphatemia on mineral metabolism.15 patients with renal transplants for 3 to 12 months, Serum Creatinine "177 micmol/1, were treated with oral phosphorus (P) for persistent hypophosphatemia.3 periods of blood and urine collection at intervals of 3 weeks. T1 under basal treatment with oral P, T2 after 3 weeks off medication with P, Ca, or P binders. T3 3 weeks after going back on oral P supplements.Serum P dropped from T1 to T2 (1.03 +/- 0.03 mmol/L to 0.83 +/- 0.03 mmol/L, p "0.0001), rising again in T3 to 1.06 +/- 0.03 mmol/L. From T1 to T2, PTHi decreased from 95.4 +/- 8.7 to 66.8 8.9pg/ml), osteocalcin rose from 3.8 +/- 1.2 to 16.6 +/- 2.3ng/ml (pTo study the effect of the correction of post-transplantation Hypophosphatemia on mineral metabolism.15 patients with renal transplants for 3 to 12 months, Serum Creatinine "177 micmol/1, were treated with oral phosphorus (P) for persistent hypophosphatemia.3 periods of blood and urine collection at intervals of 3 weeks. T1 under basal treatment with oral P, T2 after 3 weeks off medication with P, Ca, or P binders. T3 3 weeks after going back on oral P supplements.Serum P dropped from T1 to T2 (1.03 +/- 0.03 mmol/L to 0.83 +/- 0.03 mmol/L, p "0.0001), rising again in T3 to 1.06 +/- 0.03 mmol/L. From T1 to T2, PTHi decreased from 95.4 +/- 8.7 to 66.8 8.9pg/ml), osteocalcin rose from 3.8 +/- 1.2 to 16.6 +/- 2.3ng/ml (pOrdem dos Médicos1994-04-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2891oai:ojs.www.actamedicaportuguesa.com:article/2891Acta Médica Portuguesa; Vol. 7 No. 4 (1994): Abril; 207-10Acta Médica Portuguesa; Vol. 7 N.º 4 (1994): Abril; 207-101646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2891https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2891/2276Ponce, PGusmão, LAdragão, TBruges, MGomes, E MAntunes, Jinfo:eu-repo/semantics/openAccess2022-12-20T11:01:19Zoai:ojs.www.actamedicaportuguesa.com:article/2891Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:18:02.977224Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.
Consequências no metabolismo mineral da correcção da hipofosfatemia pós-transplante.
title Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.
spellingShingle Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.
Ponce, P
title_short Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.
title_full Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.
title_fullStr Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.
title_full_unstemmed Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.
title_sort Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism.
author Ponce, P
author_facet Ponce, P
Gusmão, L
Adragão, T
Bruges, M
Gomes, E M
Antunes, J
author_role author
author2 Gusmão, L
Adragão, T
Bruges, M
Gomes, E M
Antunes, J
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Ponce, P
Gusmão, L
Adragão, T
Bruges, M
Gomes, E M
Antunes, J
description To study the effect of the correction of post-transplantation Hypophosphatemia on mineral metabolism.15 patients with renal transplants for 3 to 12 months, Serum Creatinine "177 micmol/1, were treated with oral phosphorus (P) for persistent hypophosphatemia.3 periods of blood and urine collection at intervals of 3 weeks. T1 under basal treatment with oral P, T2 after 3 weeks off medication with P, Ca, or P binders. T3 3 weeks after going back on oral P supplements.Serum P dropped from T1 to T2 (1.03 +/- 0.03 mmol/L to 0.83 +/- 0.03 mmol/L, p "0.0001), rising again in T3 to 1.06 +/- 0.03 mmol/L. From T1 to T2, PTHi decreased from 95.4 +/- 8.7 to 66.8 8.9pg/ml), osteocalcin rose from 3.8 +/- 1.2 to 16.6 +/- 2.3ng/ml (p
publishDate 1994
dc.date.none.fl_str_mv 1994-04-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2891
oai:ojs.www.actamedicaportuguesa.com:article/2891
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2891
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/2891
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2891
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2891/2276
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 7 No. 4 (1994): Abril; 207-10
Acta Médica Portuguesa; Vol. 7 N.º 4 (1994): Abril; 207-10
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130632833466368